Last Updated: August 9, 2026

Patent: 9,220,631

✉ Email this page to a colleague

Summary for Patent: 9,220,631

Title:	Syringe
Abstract:	The present invention relates to a syringe, particularly to a small volume syringe such as a syringe suitable for ophthalmic injections.
Inventor(s):	Sigg; Juergen (Loerrach, DE), Royer; Christophe (Munich, DE), Bryant; Andrew Mark (Basel Land, CH), Buettgen; Heinrich Martin (Rheinfelden, CH), Picci; Marie (Ranspack-le-bas, FR)
Assignee:	Novartis AG (Basel, CH)
Application Number:	13/750,352
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,220,631
Patent Claims:	see list of patent claims

Details for Patent 9,220,631

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	LUCENTIS	ranibizumab	Injection	125156	June 30, 2006	⤷ Start Trial	2033-01-25
Genentech, Inc.	LUCENTIS	ranibizumab	Injection	125156	August 10, 2012	⤷ Start Trial	2033-01-25
Genentech, Inc.	LUCENTIS	ranibizumab	Injection	125156	October 13, 2016	⤷ Start Trial	2033-01-25
Genentech, Inc.	LUCENTIS	ranibizumab	Injection	125156	March 20, 2018	⤷ Start Trial	2033-01-25
Regeneron Pharmaceuticals, Inc.	EYLEA	aflibercept	Injection	125387	November 18, 2011	⤷ Start Trial	2033-01-25
Regeneron Pharmaceuticals, Inc.	EYLEA	aflibercept	Injection	125387	August 16, 2018	⤷ Start Trial	2033-01-25
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 9,220,631

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
South Africa	201409411	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2014005728	⤷ Start Trial
United States of America	2014012227	⤷ Start Trial
Taiwan	201402152	⤷ Start Trial
Taiwan	I632920	⤷ Start Trial
Tunisia	2014000517	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.